# Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX

> **NCT01121354** · PHASE1 · COMPLETED · sponsor: **B. Braun Medical Inc.** · enrollment: 24 (actual)

## Conditions studied

- Infection

## Interventions

- **DRUG:** Cefazolin 2g for Injection USP and Dextrose Injection USP
- **DRUG:** Cefazolin 1.5g

## Key facts

- **NCT ID:** NCT01121354
- **Lead sponsor:** B. Braun Medical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01121354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01121354, "Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT01121354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*